World Anti-Doping Code Commentary Project

The first fully comprehensive resource for anti-doping practitioners, providing guidance along all steps of the doping control process. With topics ranging from signatory compliance to application of the sanctioning regime, the commentary will assist the anti-doping movement to achieve a more effective implementation and harmonized interpretation of the 2015 World Anti-Doping Code.

Home Blog Style 1

/Home Blog Style 1
­

Avada includes a blog shortcode you can use anywhere on the site!

This blog shortcode was submitted by Markus, one of our 20,000+ Avada users! It just goes to show what an awesome community we have, everyone is willing to help & share ideas. Dont wait, be apart of it today!

Meldonium and Moral Fault: Five Lessons Learned from the Sharapova ITF Tribunal Decision

By |June 10th, 2016|Intentional violations, No Significant Fault or Negligence|

In Fall 2015, WADA announced its decision to add the anti-ischemic drug “Meldonium” to its Prohibited List with effect on 1 January 2016, after the Monitoring Program and observation period 2015 revealed “evidence of its [...]

Talk is Cheap: The Daiders CAS Award on the Evidence Needed for a Contaminated Supplement Defense

By |October 13th, 2015|Disqualification of results, Evidence of doping, No Significant Fault or Negligence|

CAS Award: CAS 2014/A/3615, WADA v. Lauris Daiders, Jànis Daiders, and FIM, January 30, 2015 While the fact pattern in this case – the unexplained presence of a Prohibited Substance allegedly attributable to supplement contamination [...]

The ISSF v. WADA CAS Award: Another Therapeutic Use Exemption Request for Beta Blockers Shot Down

By |August 10th, 2015|Therapeutic Use Exemptions|

CAS Award: CAS 2013/A/3437, International Shooting Sport Federation v. WADA,  December 18, 2014. The granting of Therapeutic Use Exemptions (“TUE”) is an important aspect of an Anti-Doping Organization’s daily activities. It is also the only [...]

The Stewart CAS Award: “Paperwork” Violations and Principles Surrounding “Retrospective” Therapeutic Use Exemptions

By |June 15th, 2015|No Significant Fault or Negligence|

CAS Award: CAS 2014/A/3876, Stewart v. FIM, April 27, 2015. FACTS James Stewart, a professional motocross and supercross rider, had been regularly taking the medication “Adderall” since 2012,[1] when he underwent an In-Competition Doping Control [...]

The Lallukka CAS Award: The End of an Unsettled Era for Human Growth Hormone Cases?

By |April 29th, 2015|Evidence of doping, Science in anti-doping|

CAS Award: WADA v. Lallukka, CAS 2014/A/3488, November 20, 2014 FACTS In September 2011, the Finnish cross-country skier Juha Lallukka (the “skier”), a National-Level Athlete affiliated with the Finnish Ski Association, was subjected to an [...]

Biological passports and the 2015 Code: Will four-year bans for blood doping become the new norm?

By |February 3rd, 2015|Intentional violations|

Download the Bekele Blog Post HERE CAS Award: Alemitu Bekele Degfa v. Turkish Athletics Federation & IAAF, CAS 2013/A/3080, March 14, 2014. In this award, recently published in the CAS bulletin, Alemitu Bekele Degfa – a [...]